COVID-19 Response

CHRISTUS Good Shepherd is fully equipped to provide safe, quality care to our communities. Learn More

CHRISTUS Good Shepherd Medical Center - Marshall Receives Get With The Guidelines-Stroke Gold Plus Quality Achievement Award American Heart Association Award recognizes CHRISTUS Good Shepherd’s commitment to quality stroke care August 07, 2020

Marshall, Texas ― CHRISTUS Good Shepherd Medical Center - Marshall has received the American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Gold Plus Quality Achievement Award. The award recognizes the hospital’s commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.

CHRISTUS Good Shepherd Medical Center - Marshall earned the award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period. These measures include evaluation of the proper use of medications and other stroke treatments aligned with the most up-to-date, evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients. Before discharge, patients should also receive education on managing their health, get a follow-up visit scheduled, as well as other care transition interventions.

“At CHRISTUS Good Shepherd Medical Center - Marshall, we are dedicated to improving the quality of care for our stroke patients by implementing the American Heart Association’s Get With The Guidelines-Stroke initiative,” said Jennifer Reeves, RN, MSN, ASC-BC, Stroke Program Coordinator, CHRISTUS Good Shepherd Health System. “The tools and resources provided help us track and measure our success in meeting evidenced-based clinical guidelines developed to improve patient outcomes. Because, ultimately, we are focused on providing the very best care we can to the people of Northeast Texas who rely on us during times of serious illness and injury.”

CHRISTUS Good Shepherd Medical Center - Marshall additionally received the Association’s Target: StrokeSM Honor Roll award. To qualify for this recognition, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. For those hospitals measuring Door-To-Device (DTD) times in at least 50-percent of applicable patients within 90 minutes for direct arriving and within 60 minutes for transfer qualified for the Target: Stroke Honor Roll Advanced Therapy designation.

CHRISTUS Good Shepherd Medical Center - Marshall was also awarded the Association’s Target Type 2 Diabetes Honor Roll award. To qualify for this recognition, hospitals must meet quality measures developed with more than 90-percent of compliance for 12 consecutive months for the “Overall Diabetes Cardiovascular Initiative Composite Score.”

“We are pleased to recognize CHRISTUS Good Shepherd Medical Center - Marshall for their commitment to stroke care,” said Lee H. Schwamm, M.D., national chairperson of the Quality Oversight Committee and Executive Vice Chair of Neurology, Director of Acute Stroke Services, Massachusetts General Hospital, Boston, Massachusetts. “Research has shown that hospitals adhering to clinical measures through the Get With The Guidelines quality improvement initiative can often see fewer readmissions and lower mortality rates.”

According to the American Heart Association/American Stroke Association, stroke is the No. 5 cause of death and a leading cause of adult disability in the United States. On average, someone in the U.S. suffers a stroke every 40 seconds and nearly 795,000 people suffer a new or recurrent stroke each year.